MY138183A - Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesia - Google Patents
Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesiaInfo
- Publication number
- MY138183A MY138183A MYPI20054473A MY138183A MY 138183 A MY138183 A MY 138183A MY PI20054473 A MYPI20054473 A MY PI20054473A MY 138183 A MY138183 A MY 138183A
- Authority
- MY
- Malaysia
- Prior art keywords
- compound
- hyperalgesia
- ulcer
- anaphylactic shock
- preventing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
USE OF A COMPOUND FOR PREVENTING AND TREATING INFLAMMATION. ULCER, ANAPHYLACTIC SHOCK AND HYPERALGESIA 5 THE PRESENT INVENTION RELATES TO A COMPOUND REPRESENTED BY THE FORMULA (1), METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND, AND THE USE OF SAID COMPOUND IN THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATION, ANAPHYLACTIC SHOCK, ULCER AND HYPERALGESIA BY WAY OF 10 SIMULTANEOUS INHIBITION OF ENZYMES CYCLOOXYGENASE (COX-2) AND/OR 5-LIPOXYGENASE (5-1-0). (1) 1 5 0 3' 5' 7' I R CH3 CH30 2- 6' 81 10' 3 0 20 D OT9-
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20054473 MY138183A (en) | 2005-09-23 | 2005-09-23 | Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20054473 MY138183A (en) | 2005-09-23 | 2005-09-23 | Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesia |
Publications (1)
Publication Number | Publication Date |
---|---|
MY138183A true MY138183A (en) | 2009-05-29 |
Family
ID=45756708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20054473 MY138183A (en) | 2005-09-23 | 2005-09-23 | Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesia |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY138183A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017036436A1 (en) * | 2015-09-02 | 2017-03-09 | Ustav Experimentalni Botaniky Av Cr, V.V.I. | Primin derivatives, method of preparation thereof and use thereof |
RU2647374C1 (en) * | 2017-07-19 | 2018-03-15 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for prevention of anaphylactic shock at heterological serums introduction |
-
2005
- 2005-09-23 MY MYPI20054473 patent/MY138183A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017036436A1 (en) * | 2015-09-02 | 2017-03-09 | Ustav Experimentalni Botaniky Av Cr, V.V.I. | Primin derivatives, method of preparation thereof and use thereof |
RU2647374C1 (en) * | 2017-07-19 | 2018-03-15 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for prevention of anaphylactic shock at heterological serums introduction |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005004818A3 (en) | Heterocyclic compounds and their use as anticancer agents | |
WO2001081310A8 (en) | 1-aroyl-piperidinyl benzamidines | |
WO2007139955A3 (en) | Triazole compounds that modulate hsp90 activity | |
WO2007139967A3 (en) | Triazole compounds that modulate hsp90 activity | |
WO2007139968A3 (en) | Triazole compounds that modulate hsp90 activity | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
EP2298748A3 (en) | Triazole compounds that modulate HSP90 activity | |
WO2004078712A3 (en) | Isoquinoline derivatives and methods of use thereof | |
WO2007094819A8 (en) | Triazole compounds that modulate hsp90 activity | |
WO2008092006A3 (en) | Antimicrobial compositions | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2008030412A3 (en) | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
MX2009000657A (en) | Compositions and methods for the treatment of mucositis. | |
WO2007112000A3 (en) | Treatment of pain | |
WO2008054698A3 (en) | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2007028022A3 (en) | Novel compounds as p2x7 modulators and uses thereof | |
WO2005099721A3 (en) | Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof | |
MXPA05000765A (en) | 5-aryltetrazole compounds, compositions thereof, and uses therefor. | |
WO2006108681A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria | |
TW200621773A (en) | Bicyclononene derivatives | |
WO2008073332A3 (en) | Creatine compositions for skin treatment | |
IL197513A0 (en) | Pyrazolopyrimidine derivatives and pharmaceutical compositions containing the same | |
TW200628468A (en) | Bicyclononene derivatives | |
WO2007019078A3 (en) | Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2005055943A3 (en) | Vinorelbine derivatives |